Life Sciences Tools and Services
Company Overview of ORPEGEN Pharma Gmbh
Orpegen GmbH is a pharmaceutical firm that provides recombinant proteins, amino acid products, generic peptide hormones, and thymic peptide drugs. The firm also provides diagnostic systems such as Phagotest, Bursttest Phagoburst, Ldl-Receptortest, Nk Test, Basotest, and Migratest. It also offers contract research and development services in the fields of immunology, protein chemistry, and micro and molecular biology. Orpegen was founded in 1982 and is based in Heidelberg, Germany.
Founded in 1982
49 62 21 91 050
49 62 21 91 05 10
Key Executives for ORPEGEN Pharma Gmbh
Similar Private Companies By Industry
|Alacris Theranostics GmbH||Europe|
|Amcapharm Pharmaceutical GmbH||Europe|
|AMS Advanced Medical Services GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ORPEGEN Pharma Gmbh, please visit www.orpegen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.